Loading clinical trials...

Phase I Endovenous Administration of Oncolytic Adenovirus ICOVIR-5 in Patients With Advanced or Metastatic Melanoma | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 1NCT01864759

Phase I Endovenous Administration of Oncolytic Adenovirus ICOVIR-5 in Patients With Advanced or Metastatic Melanoma

The investigators will evaluate the safety of a single endovenous infusion of ICOVIR5 in adults with locally advanced and metastatic melanoma. ICOVIR5 consists in a conditionally replicative or oncoly...

Lead sponsor: Institut Català d'Oncologia•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

RECRUITINGPhase 1/2

Phase I/II Clinical Study of JMT108 Injection for the Treatment of Advanced Malignant Melanoma

NCT07280832 · Unresectable Locally Advanced or Metastatic Melanoma

RECRUITINGEARLY Phase 1

Study of CBL0137 in Combination With Ipilimumab and Nivolumab Therapy in Melanoma

NCT05498792 · Locally Advanced or Metastatic Melanoma

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 29, 2017Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE1

Enrollment14

Start dateJan 2013

Last updatedAug 29, 2017

Condition

Locally Advanced or Metastatic Melanoma

Locations shown

Institut Català d'Oncologia - L'Hospitalet

L'Hospitalet Del Llobregat, Barcelona

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 29, 2017Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions